Plain-English translation of NCT05786417 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
LIVEBETTER is testing two common heart medications—Beta-Blockers and Calcium Channel Blockers—to see which one works better for older adults who have chest pain (stable angina) and multiple other health conditions. The trial will measure how well each medication reduces symptoms, improves daily function, and affects quality of life over one year.
Doctors aren't sure which of these two medications is the safest and most effective choice for older patients who have chest pain along with other chronic illnesses. This trial will provide clear evidence to help doctors make better treatment decisions for this group.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to take either a Beta-Blocker or a as a pill by mouth. Your doctor will choose the specific medication and dose based on what's best for you. Over 12 months, you'll have four study visits where you'll answer questions about your symptoms, take a six-minute walk test, and have your medical records reviewed. Your regular medical team will manage your medication doses as part of your normal care.
AI-generated summary from trial data · Jun 28, 2026 · Not medical advice
United States